Mackenzie Financial’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
6,768
-7,387
| -52% | -$542K | ﹤0.01% | 1230 |
|
|
2025
Q1 | $1.62M | Buy |
14,155
+7,948
| +128% | +$908K | ﹤0.01% | 842 |
|
|
2024
Q4 | $313K | Sell |
6,207
-241
| -4% | -$12.1K | ﹤0.01% | 1369 |
|
|
2024
Q3 | $298K | Hold |
6,448
| – | – | ﹤0.01% | 1194 |
|
|
2024
Q2 | $209K | Sell |
6,448
-1,811
| -22% | -$58.8K | ﹤0.01% | 1323 |
|
|
2024
Q1 | $208K | Buy |
8,259
+1,811
| +28% | +$45.6K | ﹤0.01% | 1328 |
|
|
2023
Q4 | $209K | Buy |
+6,448
| New | +$209K | ﹤0.01% | 1314 |
|
|
2023
Q3 | – | Sell |
-11,697
| Closed | -$259K | – | 1492 |
|
|
2023
Q2 | $259K | Hold |
11,697
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q1 | $253K | Hold |
11,697
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q4 | $238K | Buy |
11,697
+766
| +7% | +$15.6K | ﹤0.01% | 1171 |
|
|
2022
Q3 | $280K | Buy |
+10,931
| New | +$280K | ﹤0.01% | 1113 |
|